Pranami Drugs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.68 M
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.40 Cr
- Satisfied Charges ₹ 9.40 Cr
- Revenue Growth 20.66%
- Profit Growth -12.61%
- Ebitda -4.47%
- Net Worth 14.03%
- Total Assets 11.09%
About Pranami Drugs
Pranami Drugs Private Limited (PDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 November 2002 and has a history of 22 years and two months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.68 M.
The company currently has active open charges totaling ₹13.40 Cr. The company has closed loans amounting to ₹9.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vallabh Changani and Dipen Vagadia serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2002PTC041544
-
Company No.
041544
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 2002
-
Date of AGM
18 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Pranami Drugs Private Limited offer?
Pranami Drugs Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Pranami Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipen Vagadia
|
Director | 15-Nov-2002 | Current |
|
Vallabh Changani
|
Director | 15-Nov-2002 | Current |
Financial Performance of Pranami Drugs.
Pranami Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.66% increase. The company also saw a substantial fall in profitability, with a 12.61% decrease in profit. The company's net worth Soared by an impressive increase of 14.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pranami Drugs?
In 2023, Pranami Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ankleshwar Waste Management AssociationVallabh Changani is a mutual person
Charges (Loans)
₹134.00 M
₹93.95 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 13.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2024 | Hdfc Bank Limited | ₹13.40 Cr | Open |
| 06 Jul 2015 | Axis Bank Limited | ₹3.61 Cr | Satisfied |
| 14 Mar 2013 | The Varachcha Co-Op Bank Limited | ₹1.00 Cr | Satisfied |
| 22 Apr 2008 | Idbi Bank Ltd | ₹1.60 Cr | Satisfied |
| 18 May 2006 | Industrial Development Bank Of India Limited | ₹1.25 Cr | Satisfied |
How Many Employees Work at Pranami Drugs?
Unlock and access historical data on people associated with Pranami Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pranami Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pranami Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.